Lupin: The Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September…
Lupin (LUPIN) filed a disclosure titled "The Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026". The company is valued at about ₹92,174 crore.
What happened
Lupin (LUPIN) filed a disclosure with the exchanges on 4 November 2026 at 12:44 AM titled "The Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026".
From the filing: "Lupin Limited has submitted to the Exchange, the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026."
Company snapshot
Lupin is a mid-cap company in the Healthcare sector, with a market value of about ₹92,174 crore.
The stock last traded at ₹2,015.9, against a 52-week range of ₹1,892.9–₹2,529.5 (20.3% below the high).
Before this filing the shares had moved −0.8% over the month and −16.4% over three months. Average daily turnover over the last 20 sessions was about ₹134 crore.
Promoters held 46.85% at the end of Q1 FY27. Foreign institutions owned 22.42% and domestic institutions 24.65%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 6,268 | 1,219 | 26.7 |
| Q2 FY26 | 7,048 | 1,477.9 | 32.36 |
| Q3 FY26 | 7,168 | 1,175.6 | 25.74 |
| Q4 FY26 | 7,475 | 1,460.3 | 31.96 |
| Q1 FY27 | 8,277 | 1,415 | 30.95 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 3.6% on average the next trading day and was down 6.3% on average after five days (2 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.1% over five days; 58% of them rose the next day.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Aug 2026 | A press release dated August 06, 2026, titled "Lupin Q1 FY2027… | −3.6% | −6.3% |
| 6 Aug 2026 | , Unaudited Standalone and Consolidated Financial Results of the… | −3.6% | −6.3% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
- Stocks in Focus: NBCC (India), Lupin, and Others
- Q2 results, Nov 3: SBI, NSE, Bajaj Finserv, Solar Industries, Lupin, MCX, Graphite India, Gujarat Fluorochemicals, GSK, others to post earnings
- Q2 Results on November 3: SBI, Bajaj Finserv, Lupin, Mankind — 200+ companies set to announce earnings
- Q2 Results Today, November 3: SBI, Bajaj Finserv, Lupin, MCX to announce earnings; NSE's first since listing - Full list
- Top Q2 results today, November 3: SBI, Bajaj Finserv, Lupin, Mahanagar Gas, MCX and more companies to announce earnings
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.